Tag: Vascular Therapies
Vascular Therapies initiates enrolment in ACCESS 2 clinical trial
Vascular Therapies has announced that the first patient in the ACCESS 2 clinical trial was enrolled by Nikhil Kansal at Harbor-UCLA Medical Center in Torrance, USA.
The...
Vascular Therapies announce positive preliminary clinical results from its AV fistula...
Vascular Therapies is developing Sirogen, a proprietary sirolimus formulation for intraoperative local, perivascular drug delivery focused on improving vascular access outcomes in patients with...
